GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.
Guerenne L, Beurlet S, Said M, Gorombei P, Le Pogam C, Guidez F, de la Grange P, Omidvar N, Vanneaux V, Mills K, Mufti GJ, Sarda-Mantel L, Noguera ME, Pla M, Fenaux P, Padua RA, Chomienne C, Krief P.
Guerenne L, et al. Among authors: chomienne c.
J Hematol Oncol. 2016 Jan 27;9:5. doi: 10.1186/s13045-016-0235-8.
J Hematol Oncol. 2016.
PMID: 26817437
Free PMC article.